Scoring Systems of Peritoneal Dissemination for the Prediction of Operative Completeness in Advanced Ovarian Cancer
暂无分享,去创建一个
N. Yanaihara | A. Okamoto | H. Takano | H. Tanabe | Y. Iida | Kazu Ueda | Satoshi Hosoya | K. Ogawa | M. Saito | Kyosuke Yamada | Toshiyuki Seki | M. Takenaka | S. Odajima | H. Komazaki
[1] E. Boldo,et al. Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer , 2021, Scientific Reports.
[2] D. Matei,et al. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[3] S. Klaschik,et al. Risk Factors for Severe Complications in Ovarian Cancer Surgery , 2020, In Vivo.
[4] G. Scambia,et al. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) , 2020, International Journal of Gynecological Cancer.
[5] A. Gryparis,et al. Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models , 2020, Journal of Ovarian Research.
[6] A. Okamoto,et al. Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept , 2020, Journal of gynecologic oncology.
[7] N. Yanaihara,et al. Neoadjuvant Chemotherapy for Patients With Diaphragmatic Lesions: A Prognostic Postoperative Analysis , 2020, In Vivo.
[8] A. Okamoto,et al. Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial. , 2020, European journal of cancer.
[9] J. Sehouli,et al. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer , 2019, International Journal of Gynecological Cancer.
[10] T. Enomoto,et al. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. , 2019, Gynecologic oncology.
[11] M. Leeflang,et al. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. , 2019, The Cochrane database of systematic reviews.
[12] Zheng Feng,et al. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study , 2018, Journal of gynecologic oncology.
[13] A. Soliman,et al. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study , 2018, Geburtshilfe und Frauenheilkunde.
[14] N. Zeff. Role of laparoscopy in initial tumour staging in advanced epithelial ovarian cancer: A systematic review , 2018, Pleura and peritoneum.
[15] C. Ngô,et al. A pre-operative predictive score to evaluate the feasibility of complete cytoreductive surgery in patients with epithelial ovarian cancer , 2017, PloS one.
[16] A. Reuss,et al. TRUST: Trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO‐OVAR OP7). , 2017 .
[17] P. Valette,et al. A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[18] G. Scambia,et al. Current Recommendations for Minimally Invasive Surgical Staging in Ovarian Cancer , 2016, Current Treatment Options in Oncology.
[19] H. Kitchener,et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial , 2015, The Lancet.
[20] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[21] P. Morice,et al. Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy , 2013, International Journal of Gynecologic Cancer.
[22] G. Kenter,et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.
[23] R. Rouzier,et al. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. , 2010, American journal of obstetrics and gynecology.
[24] R. Rouzier,et al. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. , 2008, Gynecologic oncology.
[25] E. Cotte,et al. Quantitative prognostic indices in peritoneal carcinomatosis. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[26] G. Scambia,et al. A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study , 2006, Annals of Surgical Oncology.
[27] G. Georgiadis,et al. Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[28] K. Jablonski,et al. Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy , 1995, Annals of surgery.
[29] A. Kawabata,et al. Clinical Availability of Tumour Biopsy Using Diagnostic Laparoscopy for Advanced Ovarian Cancer , 2021, In Vivo.
[30] J. Escrig,et al. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.